{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T22:11:29Z","timestamp":1774908689136,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.seizure.2019.03.005","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T11:47:19Z","timestamp":1552045639000},"page":"40-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Impact of withdrawal of antiepileptic medication on the duration of focal onset seizures"],"prefix":"10.1016","volume":"67","author":[{"given":"E.","family":"Hartl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Seethaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lauseker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"R\u00e9mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Vollmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Noachtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2019.03.005_bib0005","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1528-1157.1986.tb03562.x","article-title":"Effects of drug withdrawal on location of seizure onset","volume":"27","author":"Marciani","year":"1986","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.03.005_bib0010","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1212\/WNL.41.4.508","article-title":"Clinical and electrographic effects of acute anticonvulsant withdrawal in epileptic patients","volume":"41","author":"Marks","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2019.03.005_bib0015","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/jnnp.51.7.924","article-title":"Withdrawal symptoms from phenytoin, carbamazepine and sodium valproate","volume":"51","author":"Duncan","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2019.03.005_bib0020","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1468-1331.2004.01101.x","article-title":"Changes of seizures activity during rapid withdrawal of lamotrigine","volume":"12","author":"Wang-Tilz","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.seizure.2019.03.005_bib0025","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00007691-200012000-00017","article-title":"Increased seizures after discontinuing carbamazepine: results from the gabapentin monotherapy trial","volume":"22","author":"DeToledo","year":"2000","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.seizure.2019.03.005_bib0030","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1528-1167.2009.02494.x","article-title":"Transient improvement after brief antiepileptic drug withdrawal in the epilepsy monitoring unit - possible relationship to AED tolerance","volume":"51","author":"Azar","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.03.005_bib0035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eplepsyres.2007.12.014","article-title":"Temporal pattern of oxcarbazepine and phenytoin withdrawal seizures during epilepsy monitoring","volume":"79","author":"Azar","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2019.03.005_bib0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/ane.12179","article-title":"Withdrawal of antiepileptic drugs during presurgical video-EEG monitoring: An observational study for evaluation of current practice at a referral center for epilepsy","volume":"129","author":"Henning","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2019.03.005_bib0045","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/epi4.12047","article-title":"Effective withdrawal of antiepileptic drugs in premonitoring admission to capture seizures during limited video-EEG monitoring","volume":"2","author":"Kagawa","year":"2017","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.seizure.2019.03.005_bib0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yebeh.2016.08.026","article-title":"Correlation of seizure frequency and medication down-titration rate during video-EEG monitoring","volume":"64","author":"Al Kasab","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2019.03.005_bib0055","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.35.11.1537","article-title":"Patterns of seizure activation after withdrawal of antiepileptic medication","volume":"35","author":"Marciani","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2019.03.005_bib0060","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1212\/WNL.43.11.2280","article-title":"Carbamazepine withdrawal: effects of taper rate on seizure frequency","volume":"43","author":"Malow","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2019.03.005_bib0065","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1212\/WNL.39.7.905","article-title":"Phenytoin withdrawal and seizure frequency","volume":"39","author":"Bromfield","year":"1989","journal-title":"Neurol"},{"key":"10.1016\/j.seizure.2019.03.005_bib0070","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1046\/j.1528-1157.2002.26401.x","article-title":"Seizure clustering during epilepsy monitoring","volume":"43","author":"Haut","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.03.005_bib0075","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40268-017-0197-5","article-title":"Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures","volume":"17","author":"Galiana","year":"2017","journal-title":"Drugs R D"},{"key":"10.1016\/j.seizure.2019.03.005_bib0080","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.seizure.2004.04.016","article-title":"Zonisamide: Chemistry, mechanism of action, and pharmacokinetics","volume":"13","author":"Leppik","year":"2004","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2019.03.005_bib0085","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1528-1167.2011.03109.x","article-title":"Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy","volume":"52","author":"Hanada","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.03.005_bib0090","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejphar.2011.04.064","article-title":"Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant properties","volume":"664","author":"Gillard","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.seizure.2019.03.005_bib0095","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.neuropharm.2006.02.002","article-title":"Seeking a mechanism of action for the novel anticonvulsant lacosamide","volume":"50","author":"Errington","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.seizure.2019.03.005_bib0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.seizure.2015.02.023","article-title":"Pulmonary edema following generalized tonic clonic seizures is directly associated with seizure duration","volume":"27","author":"Kennedy","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2019.03.005_bib0105","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.yebeh.2015.03.023","article-title":"Duration of focal complex, secondarily generalized tonic-clonic, and primarily generalized tonic-clonic seizures--A video-EEG analysis","volume":"49","author":"Dobesberger","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2019.03.005_bib0110","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00007691-199904000-00008","article-title":"Lamotrigine serum concentration-to-dose ratio: influence of age and concomitant antiepileptic drugs and dosage implications","volume":"21","author":"Armijo","year":"1999","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.seizure.2019.03.005_bib0115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0009-9236(96)90130-7","article-title":"Bidirectional interaction of valproate and lamotrigine in healthy subjects","volume":"60","author":"Anderson","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.seizure.2019.03.005_bib0120","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0048-9697(91)90194-J","article-title":"First-order and pseudo-first-order elimination kinetics","volume":"109\u2013110","author":"Sch\u00fc\u00fcrmann","year":"1991","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.seizure.2019.03.005_bib0125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neuroscience.2007.06.055","article-title":"High frequency stimulation or elevated K+ depresses neuronal activity in the rat entopeduncular nucleus","volume":"149","author":"Shin","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.seizure.2019.03.005_bib0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1059-1311(05)80164-5","article-title":"Decreased seizure frequency after withdrawal and reinstitution of antiepileptic drug therapy","volume":"3","author":"Doyle","year":"1994","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2019.03.005_bib0135","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.53.8.1736","article-title":"Brief antiepileptic drug withdrawal prolongs interval to next seizure","volume":"53","author":"Laowattana","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2019.03.005_bib0140","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0165-0173(95)00002-K","article-title":"Contingent tolerance to the anticonvulsant effects of carbamazepine: relationship to loss of endogenous adaptive mechanisms","volume":"20","author":"Weiss","year":"1995","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.seizure.2019.03.005_bib0145","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2008.02.016","article-title":"Effect of 21-day exposure of phenobarbital, carbamazepine and phenytoin on P-glycoprotein expression and activity in the rat brain","volume":"270","author":"Wen","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.seizure.2019.03.005_bib0150","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1528-1157.1994.tb01783.x","article-title":"Relationship of carbamazepine reduction rate to seizure frequency during inpatient telemetry","volume":"35","author":"Malow","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2019.03.005_bib0155","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00007691-200012000-00017","article-title":"Increased seizures after discontinuing carbamazepine: results from the gabapentin monotherapy trial","volume":"22","author":"DeToledo","year":"2000","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.seizure.2019.03.005_bib0160","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.clinph.2004.12.004","article-title":"Cortical excitability during prolonged antiepileptic drug treatment and drug withdrawal","volume":"116","author":"Lee","year":"2005","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.seizure.2019.03.005_bib0165","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/clpt.1982.190","article-title":"Blood-brain barrier transfer and cerebral uptake of antiepileptic drugs","volume":"32","author":"Paulson","year":"1982","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.seizure.2019.03.005_bib0170","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/0470846356.ch4","article-title":"Drug resistance in epilepsy: the role of the blood-brain barrier","volume":"243","author":"Abbott","year":"2002","journal-title":"Novartis Found Symp"},{"key":"10.1016\/j.seizure.2019.03.005_bib0175","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1093\/brain\/aws147","article-title":"Neuropathology of the blood\u2013brain barrier and pharmaco-resistance in human epilepsy","volume":"135","author":"Liu","year":"2012","journal-title":"Brain"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131118308173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131118308173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:51:49Z","timestamp":1761011509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131118308173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":35,"alternative-id":["S1059131118308173"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2019.03.005","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of withdrawal of antiepileptic medication on the duration of focal onset seizures","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2019.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}